Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CA9 Antibody (SAA0152), APC

Catalog #:   FHH37213 Specific References (99) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: FCM
Accession: Q16790
Overview

Catalog No.

FHH37213

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

APC

Target

Membrane antigen MN, P54/58N, Carbonic anhydrase 9, Renal cell carcinoma-associated antigen G250, CA-IX, CAIX, pMW1, Carbonic anhydrase IX, RCC-associated antigen G250, Carbonate dehydratase IX, CA9, MN, G250

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q16790

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0152

Data Image
References

Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: Bench to clinical applications., PMID:40154235

Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: Bench to clinical applications., PMID:40154235

β1 Integrin/FAK signaling regulates interleukin-8 production in human gingival epithelial Ca9-22 cells., PMID:39826873

β1 Integrin/FAK signaling regulates interleukin-8 production in human gingival epithelial Ca9-22 cells., PMID:39826873

Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources., PMID:39572570

Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources., PMID:39572570

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial., PMID:39513196

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial., PMID:39513196

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma., PMID:38948062

Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma., PMID:38834201

Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma., PMID:38834201

Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections., PMID:38828264

Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections., PMID:38828264

Carbonic anhydrase IX: An atypical target for innovative therapies in cancer., PMID:38801961

Carbonic anhydrase IX: An atypical target for innovative therapies in cancer., PMID:38801961

[Modern view on the problem of diagnostics of renal angiomioadenomatous tumor]., PMID:38650412

[Modern view on the problem of diagnostics of renal angiomioadenomatous tumor]., PMID:38650412

Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia., PMID:38627429

Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia., PMID:38627429

Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer., PMID:37748406

Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer., PMID:37748406

Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer., PMID:37306115

Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer., PMID:37306115

Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9., PMID:37210768

Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9., PMID:37210768

18F-Fluoromisonidazole-Positron Emission Tomography and Immunohistochemistry Verified Tumor Oxygenation, Stemness, and Immunosupportive Microenvironment After Preoperative Neoadjuvant Bevacizumab for Newly Diagnosed Glioblastoma., PMID:37187346

18F-Fluoromisonidazole-Positron Emission Tomography and Immunohistochemistry Verified Tumor Oxygenation, Stemness, and Immunosupportive Microenvironment After Preoperative Neoadjuvant Bevacizumab for Newly Diagnosed Glioblastoma., PMID:37187346

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities., PMID:36745503

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities., PMID:36745503

Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia., PMID:36100684

Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia., PMID:36100684

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors., PMID:35328229

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors., PMID:35328229

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors., PMID:35057692

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors., PMID:35057692

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX., PMID:34742153

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX., PMID:34742153

ZCCHC14 regulates proliferation and invasion of non-small cell lung cancer through the MAPK-P38 signalling pathway., PMID:33345444

ZCCHC14 regulates proliferation and invasion of non-small cell lung cancer through the MAPK-P38 signalling pathway., PMID:33345444

Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management., PMID:32998233

Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management., PMID:32998233

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma., PMID:32816890

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma., PMID:32816890

Effective inhibition of tumor in vivo with a novel DNA vaccine targeting chimeric G250., PMID:32706085

Effective inhibition of tumor in vivo with a novel DNA vaccine targeting chimeric G250., PMID:32706085

Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing., PMID:32515934

Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing., PMID:32515934

Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)., PMID:32452709

Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)., PMID:32452709

Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application., PMID:32392161

Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application., PMID:32392161

New Gene Variants Associated with the Risk of Chronic HBV Infection., PMID:32297155

New Gene Variants Associated with the Risk of Chronic HBV Infection., PMID:32297155

A bioconjugated MoS2 based nanoplatform with increased binding efficiency to cancer cells., PMID:32065173

A bioconjugated MoS2 based nanoplatform with increased binding efficiency to cancer cells., PMID:32065173

Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging., PMID:32048471

Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging., PMID:32048471

Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts., PMID:31624303

Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts., PMID:31624303

New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples., PMID:31349673

New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples., PMID:31349673

CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins., PMID:31167468

CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins., PMID:31167468

Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial., PMID:30694523

Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial., PMID:30694523

Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma., PMID:30635792

Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma., PMID:30635792

Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing., PMID:30391716

Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing., PMID:30391716

Different expression patterns of carbonic anhydrase IX in oral lichen planus and leukoplakia., PMID:30383070

Different expression patterns of carbonic anhydrase IX in oral lichen planus and leukoplakia., PMID:30383070

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma., PMID:30322727

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma., PMID:30322727

Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype., PMID:30203645

Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype., PMID:30203645

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5., PMID:29872736

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5., PMID:29872736

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target., PMID:29865880

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target., PMID:29865880

Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab., PMID:29802988

Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab., PMID:29802988

Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ., PMID:29749469

Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ., PMID:29749469

Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion., PMID:29730017

Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion., PMID:29730017

Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers., PMID:29715036

Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers., PMID:29715036

Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2., PMID:29691298

Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2., PMID:29691298

Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4., PMID:29556567

Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4., PMID:29556567

Extracellular galectin-1 enhances adhesion to and invasion of oral epithelial cells by Porphyromonas gingivalis., PMID:29544077

Extracellular galectin-1 enhances adhesion to and invasion of oral epithelial cells by Porphyromonas gingivalis., PMID:29544077

Nano-functionalized long-period fiber grating probe for disease-specific protein detection., PMID:32254518

Nano-functionalized long-period fiber grating probe for disease-specific protein detection., PMID:32254518

Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis., PMID:29342352

Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis., PMID:29342352

The role of molecular imaging in the characterization of renal masses., PMID:29319547

The role of molecular imaging in the characterization of renal masses., PMID:29319547

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CA9 Antibody (SAA0152), APC [FHH37213]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only